Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Inventory Average (2016 - 2025)

Historic Inventory Average for Ani Pharmaceuticals (ANIP) over the last 13 years, with Q3 2025 value amounting to $142.4 million.

  • Ani Pharmaceuticals' Inventory Average rose 413.18% to $142.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.4 million, marking a year-over-year increase of 413.18%. This contributed to the annual value of $124.0 million for FY2024, which is 1451.25% up from last year.
  • Latest data reveals that Ani Pharmaceuticals reported Inventory Average of $142.4 million as of Q3 2025, which was up 413.18% from $137.9 million recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Inventory Average registered a high of $142.4 million during Q4 2024, and its lowest value of $65.7 million during Q1 2021.
  • In the last 5 years, Ani Pharmaceuticals' Inventory Average had a median value of $105.3 million in 2022 and averaged $106.7 million.
  • Per our database at Business Quant, Ani Pharmaceuticals' Inventory Average soared by 4692.83% in 2022 and then skyrocketed by 251.83% in 2023.
  • Quarter analysis of 5 years shows Ani Pharmaceuticals' Inventory Average stood at $78.2 million in 2021, then surged by 34.75% to $105.3 million in 2022, then grew by 3.37% to $108.9 million in 2023, then skyrocketed by 30.78% to $142.4 million in 2024, then dropped by 0.01% to $142.4 million in 2025.
  • Its last three reported values are $142.4 million in Q3 2025, $137.9 million for Q2 2025, and $137.1 million during Q1 2025.